Mid West One Financial Group, Inc. Amgen Inc Transaction History

Mid West One Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $52,496 - $62,075	-245 Reduced 20.61%	944 $209,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $4,515 - $5,504	-20 Reduced 1.65%	1,189 $287,000
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $4,580 - $5,820	20 Added 1.68%	1,209 $317,000
Q2 2022 Aug 16, 2022	BUY	$230.71 - $256.74 $274,314 - $305,263	1,189 New	1,189 $289,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Mid West One Financial Group, Inc. with notifications on news.